Nicole Negar Davarpanah's most recent trade in Cidara Therapeutics Inc was a trade of 450 Common Stock done . Disclosure was reported to the exchange on Dec. 29, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cidara Therapeutics Inc | Nicole Negar Davarpanah | Chief Medical Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 29 Dec 2025 | 450 | 20,886 (0%) | 0% | 0 | Common Stock | |
| Cidara Therapeutics Inc | Nicole Negar Davarpanah | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 219.60 per share. | 10 Dec 2025 | 10,332 | 21,286 (0%) | 0% | 219.6 | 2,268,907 | Common Stock |
| Cidara Therapeutics Inc | Nicole Davarpanah Negar | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 62.86 per share. | 11 Sep 2025 | 474 | 31,418 (0%) | 0% | 62.9 | 29,797 | Common Stock |
| Cidara Therapeutics Inc | Nicole Negar Davarpanah | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2025 | 20,000 | 20,000 | - | - | Employee Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Nicole Negar Davarpanah | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2025 | 10,000 | 31,692 (0%) | 0% | 0 | Common Stock |